Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Use of Dexmedetomidine in a Parturient With Multiple Endocrine Neoplasia Type 2A Undergoing Adrenalectomy and Thyroidectomy: A Case Report

Faulkner, Amanda L. MD*; Swanson, Eric MD*; McLarney, Thomas L. MD*; Lee, Cortney Y. MD; Rebel, Annette MD*

doi: 10.1213/XAA.0000000000000861
Case Reports
Buy

Dexmedetomidine is a selective α2-agonist, frequently used in perioperative medicine as anesthesia adjunct. The medication carries a Food and Drug Administration pregnancy category C designation and is therefore rarely used for parturients undergoing nonobstetric surgery. We are reporting the use of dexmedetomidine in the anesthetic management of a parturient undergoing minimally invasive unilateral adrenalectomy for pheochromocytoma during the second trimester of pregnancy. Additionally, because of the multiple endocrine neoplasia type 2A constellation with diagnosis of medullary thyroid cancer, the patient underwent a total thyroidectomy 1 week after the adrenalectomy.

From the Departments of *Anesthesiology

Surgery, University of Kentucky, Lexington, Kentucky.

Accepted for publication July 3, 2018.

Funding: None.

The authors declare no conflicts of interest.

Address correspondence to Annette Rebel, MD, Department of Anesthesiology, University of Kentucky, 800 Rose St, N 202 Lexington, KY 40536. Address e-mail to arebe2@uky.edu.

Copyright © 2018 International Anesthesia Research Society
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website